LMNA and Hutchinson-Gilford progeria syndrome: Several gene therapy approaches have recently been tested in mouse models of HGPS, ranging from disrupting the mutant allele with CRISPR/Cas9 indels(2, 3), correcting the mutant allele with base editing(4), or interfering with the unique RNA splicing event that produces the Progerin transcript(5–8).